The government has awarded funding of £12 million to projects across the UK that are researching technology to support people with addictions.
One of the projects pairs a chest-worn sensor that monitors breathing to a mobile device that sends out an immediate alert to nearby antidote carriers and emergency services if an overdose is detected, helping people get potentially life-saving treatment as soon as possible.
Another study will look at how VR can be used to help people overcome their triggers for cocaine addiction. People will be assessed using watch-like devices to determine which cues in their environment lead to a drug craving by measuring physical changes to the body. VR will then be used to create realistic situations to repeatedly expose people to triggers in a safe environment.
The research is being funded through the Addiction Healthcare Goals programme, which is run by the Office for Life Sciences (OLS). Around £12 million has been awarded to 11 projects across eight organisations in the UK.
Minister for public health and prevention, Andrew Gwynne said: "Drug addiction devastates lives and rips apart families, and this government is committed to gripping this problem.
"We’re determined to harness the full potential of cutting-edge technology to save thousands of lives across the country. I want the UK to lead the way in championing innovation to end the harmful effects of addiction."
Science minister Lord Vallance said: "The UK’s life sciences sector plays a critical role in finding new ways to tackle the biggest challenges facing healthcare, including the devastating impact of addiction. The Addiction Healthcare Goals Programme is testament to our commitment to bringing together researchers, clinicians, and innovators to create real change.
"From wearable technology to AI-powered tools, these innovative projects highlight the power of collaboration in delivering life-saving treatments. By investing in these partnerships, we are tackling addiction head-on and ensuring that cutting-edge science reaches those who need it most, improving public health across the UK."